SCHEMBL7747582

SCHEMBL7747582

NOC(=O)CCc1ccc(Cl)nc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.48
ALDH1A1 P00352 2/20 0.46
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
P4HTM Q9NXG6 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ATM Q13315 1/20 0.40
MAPT P10636 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NAPRT Q6XQN6 1/20 0.40
EPHX1 P07099 1/20 0.39
F2 P00734 1/20 0.38
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38
PRSS3 P35030 1/20 0.38
TPSAB1 Q15661 1/20 0.38
TPSD1 Q9BZJ3 1/20 0.38
TPSG1 Q9NRR2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3536589 0.98 FFAR1 (0.47) FFAR1ALDH1A1RAB9ANPC1P4HTM
SCHEMBL29935643 0.81 FFAR1 (0.51) FFAR1ALDH1A1RAB9ANPC1P4HTM
SCHEMBL8663044 0.81 CYP4F2 (0.58) FFAR1ALDH1A1RAB9ANPC1KMT2A
SCHEMBL24867549 0.80 FFAR1 (0.69) FFAR1ALDH1A1P4HTMNAPRT
SCHEMBL5717114 0.78 ALDH1A1 (0.58) FFAR1ALDH1A1RAB9ANPC1P4HTM
SCHEMBL5012153 0.77 ALDH1A1 (0.49) FFAR1ALDH1A1RAB9ANPC1MEN1
SCHEMBL8496431 0.75 FFAR1 (0.44) FFAR1ALDH1A1MAPTL3MBTL1
SCHEMBL4624381 0.74 GAA (0.43) ALDH1A1MAPTL3MBTL1
SCHEMBL6665672 0.72 CYP4Z1 (0.50) ALDH1A1RAB9ANPC1MEN1KMT2A
SCHEMBL5606900 0.72 ESR1 (0.50) ALDH1A1MEN1KMT2AATMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1133489-A1 ISONIPECOTAMIDES FOR THE TREATMENT OF INTEGRIN-MEDIATED DISORDERS Ortho-McNeil Pharmaceutical, Inc. (US) 2001-09-19 EP disclosed
WO-2001023376-A1 ISONIPECOTAMIDES FOR THE TREATMENT OF INTEGRIN-MEDIATED DISORDERS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-04-05 WO disclosed